$80.71 -0.77 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - New York Stock Exchange, Inc.

Sep. 26, 2016 | 01:29 PM

Partner Headlines

  1. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 13:20PM EST
  2. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 12:13PM EST
  3. Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, M&A News

    Investors Business Daily | Jul. 22, 2016 | 12:25PM EST
  4. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  5. Roche Holdings Definitely Not a Lumbering Giant

    GuruFocus | Jul. 11, 2016 | 13:24PM EST
  6. Valeant's Share Price Continues to Decline

    GuruFocus | Feb. 5, 2016 | 15:10PM EST
  7. Earnings Recap For January 27

    Benzinga | Jan. 27, 2016 | 17:17PM EST
  8. 10 Fund Managers Are Totally Wrong on GlaxoSmithKline

    GuruFocus | Jan. 26, 2016 | 14:59PM EST
  9. Guru Stocks at 52-Week Lows

    GuruFocus | Jan. 26, 2016 | 12:26PM EST
  10. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD | Jan. 15, 2016 | 17:30PM EST
  11. Berkshire Hathaway, Wells Fargo, China Mobile, Novartis, Bank of America Reach 52-Week Lows

    GuruFocus | Jan. 11, 2016 | 13:36PM EST
  12. Novartis Announces Collaboration and Licensing Agreement with Surface Oncology

    Benzinga | Jan. 11, 2016 | 04:19AM EST
  13. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  14. 3 Potential Blockbuster Drugs Launching in 2016

    IBD | Jan. 6, 2016 | 09:42AM EST
  15. Berkshire Hathaway, China Mobile, Novartis, Oracle, PetroChina Near 52-Week Lows

    GuruFocus | Jan. 4, 2016 | 12:52PM EST
  16. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  17. Novartis Announces New CTL019 Study Data Demonstrating Overall Response in Adults with Certain Types of Lymphoma at #ASH2015

    Benzinga | Dec. 6, 2015 | 08:43AM EST
  18. Novartis Announces Phase III Studies of Jakavi Show Disease Improvement in Patients with Myelofibrosis and Polycythemia Vera

    Benzinga | Dec. 5, 2015 | 10:18AM EST
  19. Weekend Watch: Yahoo's Fate, Blood Cancer Fighters

    IBD | Dec. 5, 2015 | 08:02AM EST
  20. Amgen Expands Work With Merck, Files Biosimilar In EU

    IBD | Dec. 4, 2015 | 13:46PM EST
  21. Blood-Cancer Drugs In Focus

    IBD | Dec. 2, 2015 | 18:47PM EST
  22. Blood-Cancer Fighters To Strut Their Stuff At ASH

    IBD | Dec. 2, 2015 | 08:02AM EST
  23. Sanofi Chipping Away At Biogen's MS Dominance

    IBD | Nov. 30, 2015 | 11:32AM EST
  24. Skin Disease Drug Costs Jump

    IBD | Nov. 25, 2015 | 18:34PM EST
  25. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  26. Valeant, Glaxo, Novartis Skin Drug Prices Have Soared

    IBD | Nov. 25, 2015 | 17:01PM EST
  27. Novartis Announces EC Approvals for Cosentyx to Treat Patients with Ankylosing Spondylitis, Psoriatic Arthritis

    Benzinga | Nov. 23, 2015 | 04:12AM EST
  28. Goldman Sachs' Top 4 Smid-Cap Biotech Picks

    IBD | Nov. 18, 2015 | 15:36PM EST
  29. Novartis Presents New Two-year Data for Cosentyx Showing No Progression in Joint Damage in 84% of Psoriatic Arthritis Patients

    Benzinga | Nov. 7, 2015 | 20:03PM EST
  30. Celgene Reports Mixed Q3 As Cancer Rivals Rise

    IBD | Nov. 5, 2015 | 17:37PM EST
  31. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD | Nov. 3, 2015 | 08:02AM EST
  32. Guru Stocks at 52-Week Lows: NVS, WMT, IBM, AXP, CHU

    GuruFocus | Nov. 1, 2015 | 17:27PM EST
  33. AbbVie Beats Q3 Views, Offers Bullish 2020 Guidance

    IBD | Oct. 30, 2015 | 10:00AM EST
  34. Apple Upgraded, Alibaba PTs Hiked, Twitter PTs Cut

    IBD | Oct. 28, 2015 | 09:39AM EST
  35. Eli Lilly Q3 Earnings, Guidance Beat On Cost Control

    IBD | Oct. 22, 2015 | 12:36PM EST
  36. Novartis, Google Developing Smart Lenses

    FoxBusiness | Oct. 21, 2015 | 11:09AM EST
  37. Elbit Imaging Announces Novartis to Invest $5M in Gamida for ~2.5% Stake

    Benzinga | Oct. 12, 2015 | 10:35AM EST
  38. Novartis Division Alcon Receives FDA Approval for AcrySof®IQ Aspheric IOL with UltraSert Pre-loaded Delivery System

    Benzinga | Oct. 5, 2015 | 04:14AM EST
  39. US Stock Futures Up; All Eyes On Jobs Report

    Benzinga | Oct. 2, 2015 | 07:37AM EST
  40. FDA Accepts Novartis/Sandoz Regulatory Submission for Proposed Biosimilar to Enbrel

    Benzinga | Oct. 2, 2015 | 04:19AM EST
  41. Novartis Announces NEJM Publication Of Secukinumab Phase III Data Confirming Significant Efficacy In Patients With Psoriatic Arthritis

    Benzinga | Sep. 30, 2015 | 17:02PM EST
  42. Bristol-Myers, J&J Upgraded On New Drug Prospects

    IBD | Sep. 29, 2015 | 15:00PM EST
  43. Roche Drug Scores A Hit Against Stubborn Form Of MS

    IBD | Sep. 28, 2015 | 11:48AM EST
  44. Novartis Reports Patients with Aggressive Form of Melanoma Lived Average of Two+ Years When Taking Tafinlar + Mekinist

    Benzinga | Sep. 27, 2015 | 18:23PM EST
  45. Novartis' Afinito Significantly Improves Progression-Free Survival In Advanced Nonfunctional GI and Lung NET

    Benzinga | Sep. 27, 2015 | 06:48AM EST
  46. Novartis' New Heart Failure Medicine Entresto Receives CHMP Recommendation for EU Approval

    Benzinga | Sep. 25, 2015 | 04:31AM EST
  47. US Stock Futures Tumble; Jobs Report In Focus

    Benzinga | Sep. 4, 2015 | 07:09AM EST
  48. Novartis Announces EU approval for Farydak

    Benzinga | Sep. 4, 2015 | 04:45AM EST
  49. Swiss Miss: Switzerland Skirts Recession, But ETFs Struggle

    Benzinga | Aug. 28, 2015 | 14:32PM EST
  50. US Stock Futures Slide Ahead Of Deere, Foot Locker Earnings

    Benzinga | Aug. 21, 2015 | 07:06AM EST
Trading Center